Develops continuous glucose monitoring systems for diabetes management.
Jun 2026Revenue $4.97B/yrExpenses $3.83B/yr
Reached break-even Jul 2019
Figures by year
When did Dexcom become profitable?
Its revenue passed its expenses in Jul 2019. In the 12 months to Jun 2026, revenue was $4.97B and expenses $3.83B.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $4.66B | $3.75B | $912M |
| Dec 2024 | $4.03B | $3.43B | $600M |
| Dec 2023 | $3.62B | $3.02B | $598M |
| Dec 2022 | $2.91B | $2.52B | $391M |
| Dec 2021 | $2.45B | $2.18B | $266M |
| Dec 2020 | $1.93B | $1.63B | $300M |
| Dec 2019 | $1.48B | $1.33B | $142M |
| Dec 2018 | $1.03B | $1.22B | −$186M |
| Dec 2017 | $719M | $761M | −$42.5M |
| Dec 2016 | $573M | $637M | −$63.9M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.